Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

During the Trading Day
3.43 +0.185 / +5.71%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.43 +0.0007 / +0.02%
Volume: 60.1K
Health Technology

Company Description

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It develops Zerenex, an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. The company was founded in October 1998 and is headquartered in New York, NY.

Contact Information

Keryx Biopharmaceuticals, Inc.
750 Lexington Avenue
New York New York 10022
P:(212) 531-5965
Investor Relations:
(212) 531-5962



Other institutional52.86%
Mutual fund holders27.54%
Individual stakeholders14.71%

Top Executives

Gregory P. MadisonPresident, Chief Executive Officer & Director
Scott A. HolmesChief Financial Officer
Enrique PoradosuVice President-Scientific & Business Strategy
Amit SharmaVice President-Medical Affairs
Douglass H. LaidlawDirector-Medical Affairs